29936-92-3

Basic information

• Product Name: ethyl 4-(ethoxycarbonyl)phenoxyacetate
• Synonyms: ethyl 4-(ethoxycarbonyl)phenoxyacetate
• CAS NO: 29936-92-3
• Molecular Weight: 252.267
• Mol File: 29936-92-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 4-(ethoxycarbonyl)phenoxyacetate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(ethoxycarbonyl)phenoxyacetate(29936-92-3)
• EPA Substance Registry System: ethyl 4-(ethoxycarbonyl)phenoxyacetate(29936-92-3)

Safety Data

• Hazardous Substances Data: 29936-92-3(Hazardous Substances Data)

Upstream product

• 99-96-7 4-hydroxy-benzoic acid 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 105-36-2 ethyl bromoacetate 

Downstream Products

• 102196-18-9 2-(4-(hydroxymethyl)phenoxy)ethanol 
• 170799-52-7 diethyl N-<4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoyl>-L-glutamate 
• 170799-60-7 ethyl 4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoate 
• 149325-67-7 4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoic acid 
• 170799-65-2 ethyl 4-<2-(2-cyano-3-methoxy-2-cyclopentenyl)ethoxy>benzoate 
• 1027062-64-1 4-(2-Methanesulfonyloxy-ethoxy)-benzoic acid ethyl ester 
• 41386-38-3 4-(2-Bromo-ethoxy)-benzoic acid ethyl ester 
• 56703-36-7 4-(2-Iodoethoxy)-benzoic acid ethyl ester 
• 25389-23-5 ethyl 4-(2-hydroxyethoxy)benzoate 
• 30893-58-4 4-(ethoxycarbonyl)phenoxyacetic acid 

Relevant articles and documents

A synthesis method of [...] derivatives (by machine translation)

The invention discloses a [...] derivative 4 - (2 - bromine ethoxy group) [...] synthetic method, to the hydroxy benzoic acid as the starting material, through esterification, condensation, reduction, brominated to obtain the target compound, the compound is an important medical intermediates. (by machine translation)

Condensed pyrimidine derivative

A novel pyrimidine derivative having an excellent antitumor activity, which is represented by the following general formula (I) or a pharmacologically acceptable salt thereof: STR1 wherein R1 represents a hydroxyl or amino group; R2 represents a phenylene, pyridinediyl, thiendiyl, furandiyl or thiazoldiyl group, --CO2 R5 and --CO2 R6 may be the same or different from each other and each represents a carboxyl group or a carboxylic acid ester, the part STR2 A represents an oxygen atom, a group represented by the formula: STR3 (wherein R3 and R4 may be the same or different from each other and each represents a hydrogen or halogen atom or a hydrocarbon group which may be substituted, or alternatively R3 and R4 may be united to form an alkylidene group which may be substituted) or a group represented by the formula: STR4 (wherein R70 represents a hydrogen atom or a hydrocarbon group), and n is an integer of 1 to 3, provided that the compound in which R1 represents oxygen, and hydrogen is attached to nitrogen at 3-position is included in the above shown definition, a process for preparation the same, and an antitumor drug containing the same.